SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000818686-08-000069
Filing Date
2008-04-01
Accepted
2008-04-01 08:04:50
Documents
3
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 TEVA PROVIDES UPDATE ON GENERIC PREVACID? LITIGATION lansoprazole310308.htm 6-K 64804
3 LOGO image001.jpg GRAPHIC 3735
4 TEVA PROVIDES UPDATE ON GENERIC PREVACID? LITIGATION - PRINTER FRIENDLY VERSION lansoprazole310308.pdf 6-K 254011
  Complete submission text file 0000818686-08-000069.txt   421735
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-16174 | Film No.: 08727327
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1